Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

GHJ Mickisch; A. Garin; Hendrik Van Poppel; Linda de Prijck; Richard Sylvester

doi:10.1016/s0140-6736(01)06103-7

Keywords

MedicineRenal cell carcinomaNephrectomyImmunotherapyInterferon alfaInternal medicineHazard ratioUrologyAlpha interferonGastroenterologySurgeryInterferonKidneyCancerImmunologyConfidence interval

Affiliated Institutions

Related Publications

Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer

Robert C. Flanigan , Sydney E. Salmon , Brent A. Blumenstein +6 more

Nephrectomy followed by interferon therapy results in longer survival among patients with metastatic renal-cell cancer than does interferon therapy alone.

2001 New England Journal of Medicine 1719 citations

Cytoreductive Nephrectomy in Patients With Metastatic Renal Cancer: A Combined Analysis

Robert C. Flanigan , G. Mickisch , Richard Sylvester +3 more

Cytoreductive nephrectomy appears to improve significantly overall survival in patients with metastatic renal cancer treated with interferon immunotherapy independent of patient...

2004 The Journal of Urology 869 citations

Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma

Thomas Powles , Se Hoon Park , Éric Voog +24 more

Maintenance avelumab plus best supportive care significantly prolonged overall survival, as compared with best supportive care alone, among patients with urothelial cancer who h...

2020 New England Journal of Medicine 1374 citations

Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma

Ghassan K. Abou‐Alfa , George Lau , Masatoshi Kudo +28 more

BACKGROUND: A single, high priming dose of tremelimumab (anti-cytotoxic T lymphocyte–associated antigen 4) plus durvalumab (anti–programmed cell death ligand-1), an infusion reg...

2022 NEJM Evidence 1193 citations

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness , Kevin J. Harrington , Richard Greil +97 more

Pembrolizumab is active in head and neck squamous cell carcinoma (HNSCC), with programmed cell death ligand 1 (PD-L1) expression associated with improved response. KEYNOTE-048 w...

2019 The Lancet 2928 citations

Publication Info

Year: 2001
Type: article
Volume: 358
Issue: 9286
Pages: 966-970
Citations: 1403
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1403

OpenAlex

Cite This

APA Style

                            
                                
                                    GHJ Mickisch, 
                                
                                    A. Garin, 
                                
                                    Hendrik Van Poppel
                                
                                et al.
                            
                            (2001). 
                            Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. 
                            The Lancet
                            , 358
                            (9286)
                            , 966-970.
                            https://doi.org/10.1016/s0140-6736(01)06103-7
                        

Identifiers

DOI: 10.1016/s0140-6736(01)06103-7